These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27558157)

  • 21. SLC4A11 is an EIPA-sensitive Na(+) permeable pHi regulator.
    Ogando DG; Jalimarada SS; Zhang W; Vithana EN; Bonanno JA
    Am J Physiol Cell Physiol; 2013 Oct; 305(7):C716-27. PubMed ID: 23864606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexistence of Congenital Hereditary Endothelial Dystrophy and Fuchs Endothelial Corneal Dystrophy Associated With SLC4A11 Mutations in Affected Families.
    Chaurasia S; Ramappa M; Annapurna M; Kannabiran C
    Cornea; 2020 Mar; 39(3):354-357. PubMed ID: 31714402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligomerization of SLC4A11 protein and the severity of FECD and CHED2 corneal dystrophies caused by SLC4A11 mutations.
    Vilas GL; Loganathan SK; Quon A; Sundaresan P; Vithana EN; Casey J
    Hum Mutat; 2012 Feb; 33(2):419-28. PubMed ID: 22072594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fuchs Endothelial Corneal Dystrophy in a Heterozygous Carrier of Congenital Hereditary Endothelial Dystrophy Type 2 with a Novel Mutation in SLC4A11.
    Kim JH; Ko JM; Tchah H
    Ophthalmic Genet; 2015; 36(3):284-6. PubMed ID: 24502824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SLC4A11 function: evidence for H
    Kao L; Azimov R; Shao XM; Abuladze N; Newman D; Zhekova H; Noskov S; Pushkin A; Kurtz I
    Am J Physiol Cell Physiol; 2020 Feb; 318(2):C392-C405. PubMed ID: 31774702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corneal dystrophy-causing SLC4A11 mutants: suitability for folding-correction therapy.
    Loganathan SK; Casey JR
    Hum Mutat; 2014 Sep; 35(9):1082-91. PubMed ID: 24916015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed onset of congenital hereditary endothelial dystrophy due to compound heterozygous SLC4A11 mutations.
    Kumawat BL; Gupta R; Sharma A; Sen S; Gupta S; Tandon R
    Indian J Ophthalmol; 2016 Jul; 64(7):492-5. PubMed ID: 27609159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Missense mutations in the sodium borate cotransporter SLC4A11 cause late-onset Fuchs corneal dystrophy.
    Riazuddin SA; Vithana EN; Seet LF; Liu Y; Al-Saif A; Koh LW; Heng YM; Aung T; Meadows DN; Eghrari AO; Gottsch JD; Katsanis N
    Hum Mutat; 2010 Nov; 31(11):1261-8. PubMed ID: 20848555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Observation of nine previously reported and 10 non-reported
    Moazzeni H; Javadi MA; Asgari D; Khani M; Emami M; Moghadam A; Panahi-Bazaz MR; Hosseini Tehrani M; Karimian F; Hosseini B; Nekuie Moghadam T; Hassanpour H; Akbari MT; Elahi E
    Br J Ophthalmol; 2020 Nov; 104(11):1621-1628. PubMed ID: 31420327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Energy Shortage in Human and Mouse Models of SLC4A11-Associated Corneal Endothelial Dystrophies.
    Zhang W; Frausto R; Chung DD; Griffis CG; Kao L; Chen A; Azimov R; Sampath AP; Kurtz I; Aldave AJ
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):39. PubMed ID: 32721020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Borate transporter SLC4A11 mutations cause both Harboyan syndrome and non-syndromic corneal endothelial dystrophy.
    Desir J; Moya G; Reish O; Van Regemorter N; Deconinck H; David KL; Meire FM; Abramowicz MJ
    J Med Genet; 2007 May; 44(5):322-6. PubMed ID: 17220209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biosynthetic and functional defects in newly identified SLC4A11 mutants and absence of COL8A2 mutations in Fuchs endothelial corneal dystrophy.
    Soumittra N; Loganathan SK; Madhavan D; Ramprasad VL; Arokiasamy T; Sumathi S; Karthiyayini T; Rachapalli SR; Kumaramanickavel G; Casey JR; Rajagopal R
    J Hum Genet; 2014 Aug; 59(8):444-53. PubMed ID: 25007886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vps35-deficiency impairs SLC4A11 trafficking and promotes corneal dystrophy.
    Liu W; Tang FL; Lin S; Zhao K; Mei L; Ye J; Xiong WC
    PLoS One; 2017; 12(9):e0184906. PubMed ID: 28934248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corneal dystrophy mutations R125H and R804H disable SLC4A11 by altering the extracellular pH dependence of the intracellular pK that governs H
    Quade BN; Marshall A; Parker MD
    Am J Physiol Cell Physiol; 2022 Oct; 323(4):C990-C1002. PubMed ID: 35993514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cytoplasmic domain is essential for transport function of the integral membrane transport protein SLC4A11.
    Loganathan SK; Lukowski CM; Casey JR
    Am J Physiol Cell Physiol; 2016 Jan; 310(2):C161-74. PubMed ID: 26582474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Slc4a11 gene disruption in mice: cellular targets of sensorineuronal abnormalities.
    Lopez IA; Rosenblatt MI; Kim C; Galbraith GC; Jones SM; Kao L; Newman D; Liu W; Yeh S; Pushkin A; Abuladze N; Kurtz I
    J Biol Chem; 2009 Sep; 284(39):26882-96. PubMed ID: 19586905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational spectrum of the SLC4A11 gene in autosomal recessive congenital hereditary endothelial dystrophy.
    Sultana A; Garg P; Ramamurthy B; Vemuganti GK; Kannabiran C
    Mol Vis; 2007 Jul; 13():1327-32. PubMed ID: 17679935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in the Corneal Endothelial Dystrophy-Associated Gene SLC4A11 Render the Cells More Vulnerable to Oxidative Insults.
    Roy S; Praneetha DC; Vendra VP
    Cornea; 2015 Jun; 34(6):668-74. PubMed ID: 25811729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of mutations in the SLC4A11 gene in patients with recessive congenital hereditary endothelial dystrophy.
    Hemadevi B; Veitia RA; Srinivasan M; Arunkumar J; Prajna NV; Lesaffre C; Sundaresan P
    Arch Ophthalmol; 2008 May; 126(5):700-8. PubMed ID: 18474783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital hereditary endothelial dystrophy caused by SLC4A11 mutations progresses to Harboyan syndrome.
    Siddiqui S; Zenteno JC; Rice A; Chacón-Camacho O; Naylor SG; Rivera-de la Parra D; Spokes DM; James N; Toomes C; Inglehearn CF; Ali M
    Cornea; 2014 Mar; 33(3):247-51. PubMed ID: 24351571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.